APA (7th ed.) Citation

Muendlein, A., Gasser, K., Kinz, E., Stark, N., Leiherer, A., Rein, P., . . . Lang, A. H. (2014). Evaluation of the prevalence and prospective clinical impact of the JAK2 V617F mutation in coronary patients. American journal of hematology, 89(3), 295-301. https://doi.org/10.1002/ajh.23632

Chicago Style (17th ed.) Citation

Muendlein, Axel, et al. "Evaluation of the Prevalence and Prospective Clinical Impact of the JAK2 V617F Mutation in Coronary Patients." American Journal of Hematology 89, no. 3 (2014): 295-301. https://doi.org/10.1002/ajh.23632.

MLA (9th ed.) Citation

Muendlein, Axel, et al. "Evaluation of the Prevalence and Prospective Clinical Impact of the JAK2 V617F Mutation in Coronary Patients." American Journal of Hematology, vol. 89, no. 3, 2014, pp. 295-301, https://doi.org/10.1002/ajh.23632.